At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.

Products, services, technology

Stämm is an End-to-End Provider encouraging free flow of information between R&D, manufacturing, analytical, quality, engineering,& sourcing. We have developed the first 3D printed microfluidic-bioreactor of continuous production for monoclonal antibodies and cell therapies.

Location
Additional address info
  • BioArk
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2016
  • Number of employees in Switzerland
    1-9

You may also be interested in